New Agents for the Treatment of Prostate Cancer
How can 5 new novel agents impact prostate cancer treatment?
September 3, 2014|Federal Practitioner
Author and Disclosure Information
Dr. Guru Sonpavde discusses the progress in treatments for patients with prostate cancer. Listen to the interview to learn about the 5 novel agents for metastatic castration-resistant prostate cancer and how the understanding of the biology of prostate cancer is changing.
Dr. Sonpavde is one of the authors of "A Focus on Metastatic Castration-Resistant Prostate Cancer," which appeared in the Advances in Hematology and Oncology special issue.